Genetics-Related Cancers
What Are Genetics-Related Cancers?
Genetics-related cancers are cancers in which changes in genetic material influence how cells grow, divide and function. These changes can affect genes responsible for regulating cell growth, repairing damaged DNA or preventing abnormal cells from developing. When these protective mechanisms are disrupted, cells may begin to multiply uncontrollably, potentially leading to cancer.
Genetic changes can arise during a person’s lifetime or be present from birth. Some occur within individual cells as part of the ageing process or through exposure to environmental factors, while others are inherited from a biological parent. Although both types can contribute to cancer development, they have different implications for an individual’s health and may affect family members in different ways.
Importantly, a genetic association with cancer does not mean that the disease will inevitably develop. Genetic changes may increase susceptibility, influence how a cancer behaves or contribute to its progression, but cancer development usually involves a combination of genetic, biological and environmental factors. Understanding these relationships helps explain why cancers can develop differently between individuals and why genetic factors are one important part of cancer research and prevention.
How Do Genetic Changes Contribute to Cancer Development?
Genetic changes can disrupt the cellular processes that regulate growth, DNA repair and cell division. When these protective mechanisms are affected, abnormal cells may survive and multiply, potentially contributing to cancer development.
Changes in Cellular DNA
Changes in DNA can affect genes involved in controlling cell growth, maintaining cellular function and protecting genetic material. These changes may arise during a person's lifetime or be present from birth.
Disruption of Growth Control
Changes affecting growth-regulating genes may increase signals that encourage cell division or weaken the mechanisms that normally prevent uncontrolled growth.
Impaired DNA Repair and Cell Regulation
If DNA repair mechanisms are affected, additional genetic damage may accumulate. Changes in other protective processes may also allow abnormal cells to survive rather than being repaired or eliminated.
Abnormal Cell Growth
As multiple changes accumulate, some cells may begin dividing abnormally, evade normal growth controls and acquire the ability to form a tumour.
Cancer development is usually a multi-step process. Genetic changes can disrupt several protective mechanisms, but a single genetic change does not necessarily cause cancer. The outcome depends on the combination of genetic alterations and other biological and environmental factors.
What Is the Difference Between Inherited and Acquired Genetic Changes in Cancer?
Genetic changes associated with cancer can be broadly classified as inherited (germline) or acquired (somatic). The key difference is when these changes arise, which cells contain them and whether they can be passed on to future generations.
| Aspect | Inherited (Germline) Changes | Acquired (Somatic) Changes |
|---|---|---|
| When They Occur | Present from conception, either inherited from a biological parent or arising as a new genetic change during early development. | Develop during a person's lifetime in individual cells as they divide and accumulate genetic changes. |
| Where They Are Found | Usually present in nearly all cells of the body, including reproductive cells. | Present only in the affected cell or its descendants, such as cells within a developing tumour. |
| How They Arise | May be passed down from a biological parent or arise as a new variant during early embryonic development. | May occur through natural cellular processes, DNA replication errors or exposure to certain environmental factors. |
| Can They Be Passed to Children? | May be passed to biological children if the variant is present in reproductive cells and is inherited. | Generally cannot be passed to children because they are not present in reproductive cells. |
| Role in Cancer | Certain inherited variants can increase a person's susceptibility to developing particular cancers. | Some acquired changes can directly contribute to tumour development by disrupting normal cellular processes. |
Inherited and acquired genetic changes can both contribute to cancer development. A person with an inherited cancer-associated variant may also acquire additional somatic changes in certain cells during their lifetime. These changes can work together to influence tumour development, but neither type of genetic change alone means that cancer is inevitable.
Which Types of Cancer Are Associated with Inherited Genetic Variants?
Certain inherited genetic variants can increase a person's susceptibility to particular types of cancer. These variants may affect genes involved in DNA repair, cell growth and other processes that help maintain normal cellular function. Some are associated with specific hereditary cancer syndromes, while others are linked to an increased risk of one or more cancer types.
| Cancer Type | Associated Genes |
|---|---|
| Breast and ovarian cancer | BRCA1, BRCA2 |
| Colorectal and endometrial cancer | MLH1, MSH2, MSH6, PMS2 |
| Pancreatic cancer | BRCA1, BRCA2, PALB2, ATM |
| Prostate cancer | BRCA1, BRCA2, HOXB13 |
| Certain endocrine cancers and tumours | RET, MEN1 |
These examples represent some of the recognised associations between inherited genetic variants and cancer. The specific cancer risks and associated conditions vary between genes. For example, inherited changes in RET are associated with medullary thyroid cancer, while pathogenic variants in MEN1 can cause multiple endocrine tumours, some of which may be malignant.
Importantly, inheriting a pathogenic variant does not mean that cancer will inevitably develop. The level of risk depends on the particular gene and variant, as well as other genetic, biological and environmental factors.
What Are the Main Hereditary Cancer Syndromes?
Hereditary cancer syndromes are conditions caused by inherited pathogenic variants in genes that normally help regulate cell growth, repair DNA damage or prevent abnormal cell development. Each syndrome is associated with a distinct pattern of genetic changes and an increased susceptibility to certain types of cancer. Some affect several organs, while others are more closely linked to specific cancer types. Cancer genetic counselling can help individuals understand the implications of these inherited variants and how they may affect their families.
Hereditary Breast and Ovarian Cancer (HBOC)
Hereditary Breast and Ovarian Cancer syndrome is most commonly associated with pathogenic variants in the BRCA1 and BRCA2 genes. These genes play an important role in repairing damaged DNA. Inherited variants can increase susceptibility to breast and ovarian cancer, as well as prostate and pancreatic cancer.
Lynch Syndrome
Lynch syndrome is associated with inherited pathogenic variants affecting DNA mismatch repair genes, including MLH1, MSH2, MSH6 and PMS2. Certain deletions involving EPCAM can also contribute to the condition. It is particularly associated with colorectal and endometrial cancer, although other cancer types may also occur.
Familial Adenomatous Polyposis (FAP)
Familial Adenomatous Polyposis is primarily caused by pathogenic variants in the APC gene, which helps regulate cell growth. The condition is characterised by the development of numerous adenomatous polyps in the colon and rectum. Without appropriate clinical management, these polyps can progress to colorectal cancer. FAP may also be associated with certain other tumours, including those affecting the upper gastrointestinal tract and thyroid.
Li-Fraumeni Syndrome
Li-Fraumeni syndrome is associated with inherited pathogenic variants in the TP53 gene, which plays a key role in controlling cell division and responding to DNA damage. People with this syndrome have an increased susceptibility to several cancer types, including soft-tissue and bone sarcomas, breast cancer, brain tumours and adrenocortical carcinoma.
Multiple Endocrine Neoplasia (MEN)
Multiple Endocrine Neoplasia refers to a group of inherited conditions involving tumours in multiple endocrine glands. Different forms are associated with different genes. MEN1 is caused by pathogenic variants in the MEN1 gene and can involve tumours of the parathyroid glands, pituitary gland and pancreatic neuroendocrine tissues. MEN2 is associated with pathogenic variants in the RET gene and is particularly linked to medullary thyroid cancer, as well as other endocrine tumours.
These syndromes demonstrate how inherited genetic changes can influence cancer susceptibility in different organs and tissues. However, carrying a pathogenic variant does not mean that cancer will inevitably develop. The associated risks and clinical implications vary depending on the specific syndrome and genetic variant.
Do Inherited Genetic Variants Always Lead to Cancer?
No. Inheriting a pathogenic genetic variant does not mean that a person will inevitably develop cancer. Certain inherited variants can increase susceptibility to specific types of cancer, but they do not determine an individual’s future health with certainty. Cancer development is a complex process influenced by inherited genetic factors, additional changes acquired during a person’s lifetime and environmental exposures. Genetic risk assessment can help evaluate how inherited factors may contribute to an individual’s likelihood of developing certain conditions.
Understanding Genetic Predisposition and Cancer Risk
Genetic predisposition refers to an increased likelihood of developing a particular disease due to inherited genetic factors. In hereditary cancer syndromes, a person may inherit a pathogenic variant that affects the normal function of a gene involved in cell growth, DNA repair or tumour suppression. However, this increased susceptibility does not mean that cancer will necessarily develop.
For example, some people with inherited pathogenic variants in the BRCA1 or BRCA2 genes develop breast or ovarian cancer during their lifetime, while others do not. This difference highlights why inherited genetic findings should be understood in terms of increased risk rather than certainty.
What Is Genetic Penetrance?
Penetrance describes the proportion of people carrying a particular genetic variant who develop the associated condition or characteristic. In cancer genetics, it helps explain why some individuals with the same inherited pathogenic variant develop cancer while others remain unaffected.
Penetrance can be described as complete or incomplete. With complete penetrance, nearly all individuals carrying a particular variant are expected to develop the associated condition by a specified age. With incomplete penetrance, only some carriers develop the condition. For many hereditary cancer syndromes, penetrance is age-dependent, meaning that the likelihood of developing cancer may increase over time.
How Do Environmental and Lifestyle Factors Influence Cancer Development?
Inherited genetic factors are only one part of cancer development. Environmental and lifestyle-related exposures, such as tobacco smoke, ultraviolet radiation, certain infections and other carcinogenic exposures, can contribute to changes in cellular DNA and influence cancer risk.
These factors may interact with inherited susceptibility, although their effects vary depending on the type of cancer, the genetic variant and individual circumstances. This helps explain why people with similar inherited genetic backgrounds may have different health outcomes.
Why Do Other Genetic Changes Matter?
Cancer usually develops through the accumulation of multiple genetic and molecular changes rather than a single event. A person may inherit a pathogenic variant that increases susceptibility, while additional changes acquired in individual cells during their lifetime may contribute to the development of a tumour.
Other inherited genetic differences can also influence how strongly a particular pathogenic variant affects cancer susceptibility. As a result, individuals carrying variants in the same gene may not have identical risks or develop the same type of cancer.
In summary, inherited pathogenic variants can increase the likelihood of developing certain cancers, but they do not make cancer inevitable. Genetic predisposition, penetrance, environmental exposures and additional genetic changes all contribute to the complex relationship between inherited variants and cancer development.
How Has Genetic Research Changed Our Understanding of Cancer?
Advances in genomic research have transformed our understanding of cancer by revealing the genetic alterations and molecular processes involved in tumour development. By studying these changes, researchers can investigate how cancers behave, identify potential therapeutic targets and support the development of more targeted treatment approaches.
Identifying Genetic Alterations
- Genomic research examines changes in DNA found in cancer cells.
- Researchers identify mutations, gene amplifications, deletions and chromosomal rearrangements.
- These findings help distinguish genetic features associated with different tumour types.
Understanding Molecular Pathways
- Scientists investigate how genetic alterations affect cellular processes.
- Research reveals changes in pathways involved in cell growth, DNA repair, cell signalling and programmed cell death.
- This provides deeper insight into how abnormal cells develop and survive.
Identifying Potential Therapeutic Targets
- Researchers explore which altered genes, proteins or molecular pathways may be suitable targets for treatment.
- Some genetic findings reveal specific weaknesses that can potentially be exploited by therapeutic approaches.
- These discoveries help guide the investigation of new cancer treatments.
Developing Targeted Cancer Therapies
- Research findings can support the development of medicines designed to act on specific molecular targets.
- Examples include therapies directed at certain HER2 alterations, EGFR mutations and abnormal signalling pathways.
- These approaches aim to target particular cancer-related mechanisms rather than relying solely on treatments that affect rapidly dividing cells more broadly.
Genomic research has helped move cancer science towards a more molecularly informed understanding of the disease. However, not every genetic alteration is suitable for targeted treatment, and the relevance of a potential target depends on the cancer type, the specific molecular finding and the available clinical evidence.
Frequently Asked Questions About Genetics-Related Cancers
Can cancer be inherited from parents?
Some genetic changes that increase cancer susceptibility can be inherited from a biological parent. However, most cancers are not directly inherited. They usually develop through genetic changes acquired during a person’s lifetime.
Are all cancers caused by genetic mutations?
Cancer involves genetic changes that affect how cells grow and function. However, these changes are not always inherited. Many develop over time due to natural cellular processes, ageing or environmental exposures.
Can someone develop cancer without a family history of the disease?
Yes. Many people diagnosed with cancer have no known family history of the disease. Cancer can develop through acquired genetic changes, even when no inherited cancer predisposition is present.
Can the same genetic variant be associated with different types of cancer?
Yes. Some inherited genetic variants are associated with an increased susceptibility to several cancer types. For example, pathogenic variants in BRCA2 can be associated with breast, ovarian, prostate and pancreatic cancer.
What is the difference between a hereditary cancer syndrome and a family history of cancer?
A hereditary cancer syndrome is associated with an inherited pathogenic genetic variant that increases susceptibility to particular cancers. A family history of cancer simply describes cancer diagnoses among biological relatives and does not necessarily indicate an inherited genetic condition.
Can genetic changes in a tumour be passed on to children?
Most genetic changes found only in tumour cells are acquired during a person’s lifetime and cannot be passed on to children. Only genetic variants present in reproductive cells, such as eggs or sperm, can generally be inherited by the next generation.
Does every cancer have an identifiable genetic cause?
No. Although genetic changes are involved in cancer development, current scientific knowledge cannot identify a specific causal genetic alteration in every case. Cancer may result from multiple interacting factors that are not always fully understood.
Why can two people with the same hereditary cancer syndrome develop different cancers?
People with the same hereditary cancer syndrome may have different health outcomes because cancer susceptibility is influenced by several factors, including age, additional genetic differences, environmental exposures and biological variation.
Can inherited genetic changes affect cancer treatment?
Yes. Certain inherited genetic variants may provide information relevant to treatment decisions, particularly when they are associated with DNA repair mechanisms or other biological pathways targeted by specific medicines. Their clinical relevance depends on the cancer type and available evidence.
Learn More About the Genetics of Cancer
Understanding the relationship between genetics and cancer can raise important questions about inherited conditions, genetic susceptibility and the role of genomic research in cancer development. Reliable information and appropriate professional guidance can help make these complex topics easier to understand.
Explore the Genetics Behind Cancer
Genetic research continues to improve our understanding of how inherited and acquired genetic changes contribute to cancer. However, interpreting genetic information requires consideration of the specific genetic findings, their scientific significance and the wider biological context.
At London Genetics, we aim to help individuals better understand genetic concepts and the potential relevance of inherited factors to health. Our approach recognises that genetic information needs to be considered carefully, without assuming that an inherited variant necessarily leads to cancer.
If you would like to learn more about the relationship between genetics and cancer or discuss questions about inherited genetic factors, you can contact London Genetics to explore the information and guidance relevant to your circumstances.
Discuss Your Questions